Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Breast Cancer

Free Subscription Articles published in Breast Cancer Res Retrieve available abstracts of 154 articles: HTML format Text format

Single Articles

January 2012
1. PEREZ-GARCIA J , Cortes J
   Do we need biomarkers to predict the benefit of adding adjuvant taxanes for treatment of breast cancer?
   Breast Cancer Res. 2012;14:104.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. SUN Y , Rowehl LM, Huang L, Machenzie GG, et al
   Phospho-ibuprofen (MDC-917) suppresses breast cancer growth: an effect controlled by the thioredoxin system.
   Breast Cancer Res. 2012;14:R20.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. CHAY WY , Ong WS, Tan PH, Leo NQ, et al
   Validation of the Gail model for predicting individual breast cancer risk in a prospective nationwide study of 28,104 Singapore women.
   Breast Cancer Res. 2012;14:R19.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. HAWKINS OE , Richmond A
   The dynamic yin-yang interaction of CXCR4 and CXCR7 in breast cancer metastasis.
   Breast Cancer Res. 2012;14:103.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. SHEPHERD JA , Kerlikowske K
   Do fatty breasts increase or decrease breast cancer risk?
   Breast Cancer Res. 2012;14:102.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. DAI J , Hu Z, Jiang Y, Shen H, et al
   Breast cancer risk assessment with five independent genetic variants and two risk factors in chinese women.
   Breast Cancer Res. 2012;14:R17.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. KASIMIR-BAUER S , Hoffmann O, Wallwiener D, Kimmig R, et al
   Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells.
   Breast Cancer Res. 2012;14:R15.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. KIM SJ , Shin JY, Lee KD, Bae YK, et al
   MicroRNA let-7a suppresses breast cancer cell migration and invasion through down-regulation of C-C chemokine receptor type 7.
   Breast Cancer Res. 2012;14:R14.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. BUNDRED NJ , Kenemans P, Yip CH, Beckmann MW, et al
   Tibolone increases bone mineral density but also relapse in breast cancer survivors: LIBERATE Trial Bone Sub-study.
   Breast Cancer Res. 2012;14:R13.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. LAPPANO R , Santolla MF, Pupo M, Sinicropi MS, et al
    MIBE acts as antagonist ligand of both estrogen receptor alpha and GPER in breast cancer cells.
    Breast Cancer Res. 2012;14:R12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. REYAL F , Guyader C, Decraene C, Lucchesi C, et al
    Molecular profiling of patient-derived breast cancer xenografts.
    Breast Cancer Res. 2012;14:R11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. STANBERY L , Petty EM
    Steps solidifying a role for SEPT9 in breast cancer suggest that greater strides are needed.
    Breast Cancer Res. 2012;14:101.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. NEDEREND J , Duijm LE, Voogd AC, Groenewoud JH, et al
    Trends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: a population based study.
    Breast Cancer Res. 2012;14:R10.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. SCHWAB LP , Peacock DL, Majumdar D, Ingels JF, et al
    Hypoxia inducible factor-1alpha promotes primary tumor growth and tumor-initiating cell activity in breast cancer.
    Breast Cancer Res. 2012;14:R6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. BEIKI O , Hall P, Ekbom A, Moradi T, et al
    Breast cancer incidence and case fatality among 4.7 million women in relation to social and ethnic background: a population-based cohort study.
    Breast Cancer Res. 2012;14:R5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. ALESKANDARANY MA , Green AR, Benhasouna AA, Barros FF, et al
    Prognostic value of proliferation assay in the luminal, HER2 positive and triple negative biological classes of breast cancer.
    Breast Cancer Res. 2012;14:R3.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. THOMPSON HJ , Sedlacek SM, Paul D, Wolfe P, et al
    Effect of dietary patterns differing in carbohydrate and fat content on blood lipid and glucose profiles based on weight loss success of breast cancer survivors.
    Breast Cancer Res. 2012;14:R1.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2011
18. LEHTIMAKI T , Lundin M, Linder N, Sihto H, et al
    Long-term prognosis of breast cancer detected by mammography screening or other methods.
    Breast Cancer Res. 2011;13:R134.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. JACOT W , Lopez-Crapez E, Thezenas S, Senal R, et al
    Lack of EGFR activating mutations in European patients with triple negative breast cancer could emphasize geographic and ethnic variations in breast cancer mutation profiles.
    Breast Cancer Res. 2011;13:R133.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. GREENWOOD CM , Paterson AD, Linton L, Andrulis IL, et al
    A genome-wide linkage study of mammographic density, a risk factor for breast cancer.
    Breast Cancer Res. 2011;13:R132.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. PUIG T , Aguilar H, Cufi S, Oliveras G, et al
    A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines.
    Breast Cancer Res. 2011;13:R131.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. HEIKKINEN T , Greco D, Pelttari LM, Tommiska J, et al
    Variants on the promoter region of PTEN affect breast cancer progression and patient survival.
    Breast Cancer Res. 2011;13:R130.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. STAAF J , Jonsson G, Ringner M, Baldetorp B, et al
    Landscape of somatic allelic imbalances and copy number alterations in HER2-amplified breast cancer.
    Breast Cancer Res. 2011;13:R129.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. HERNANDEZ L , Magalhaes MA, Coniglio SJ, Condeelis JS, et al
    Opposing roles of CXCR4 and CXCR7 in breast cancer metastasis.
    Breast Cancer Res. 2011;13:R128.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. CHIMGE NO , Baniwal SK, Little GH, Chen YB, et al
    Regulation of Breast Cancer Metastasis by Runx2 and Estrogen Signaling: Role of SNAI2.
    Breast Cancer Res. 2011;13:R127.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. WEST NR , Milne K, Truong PT, Macpherson N, et al
    Tumor infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer.
    Breast Cancer Res. 2011;13:R126.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. GRIFFITH OL , Gray JW
    'Omic approaches to preventing or managing metastatic breast cancer.
    Breast Cancer Res. 2011;13:230.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. ADAMO B , Deal AM, Burrows E, Geradts J, et al
    Phosphatidylinositol 3-kinase (PI3K) pathway activation in breast cancer brain metastases.
    Breast Cancer Res. 2011;13:R125.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. SANKPAL NV , Mayfield JD, Willman MW, Fleming TP, et al
    Activator protein 1 (AP-1) contributes to EpCAM-dependent breast cancer invasion.
    Breast Cancer Res. 2011;13:R124.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
30. KASHIWAGI S , Yashiro M, Takashima T, Aomatsu N, et al
    Advantages of adjuvant chemotherapy for patients with triple-negative breast cancer at stage II: usefulness of prognostic markers E-cadherin and Ki67.
    Breast Cancer Res. 2011;13:R122.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. TRAN B , Bedard PL
    Luminal-B breast cancer and novel therapeutic targets.
    Breast Cancer Res. 2011;13:221.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. LAHLOU H , Muller WJ
    beta1-integrins signaling and mammary tumor progression in transgenic mouse models: implications for human breast cancer.
    Breast Cancer Res. 2011;13:229.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. TIWARY R , Yu W, Degraffenried LA, Sanders BG, et al
    Targeting cholesterol-rich microdomains to circumvent tamoxifen-resistant breast cancer.
    Breast Cancer Res. 2011;13:R120.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. DESRICHARD A , Bidet Y, Uhrhammer N, Bignon YJ, et al
    CHEK2 germline mutation contribution to hereditary breast cancer in non-BRCA-mutated families.
    Breast Cancer Res. 2011;13:R119.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. LEE YM , Lee JY, Ho CC, Hong QS, et al
    MicroRNA 34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells.
    Breast Cancer Res. 2011;13:R116.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. ALI HR , Dawson SJ, Blows FM, Provenzano E, et al
    Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance.
    Breast Cancer Res. 2011;13:R118.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. MURARO E , Martorelli D, Turchet E, Miolo G, et al
    A different immunologic profile characterizes patients with HER-2-overexpressing and HER-2-negative locally advanced breast cancer: implications for immune-based therapies.
    Breast Cancer Res. 2011;13:R117.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. TERAOKA SN , Bernstein JL, Reiner AS, Haile RW, et al
    Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer and Radiation Epidemiology (WECARE) study.
    Breast Cancer Res. 2011;13:R114.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. VICTOR BC , Anbalagan A, Mostafa Mohamed M, Sloane BF, et al
    Inhibition of cathepsin B activity attenuates extracellular matrix degradation and inflammatory breast cancer invasion.
    Breast Cancer Res. 2011;13:R115.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. 
    Abstracts of the IX Madrid Breast Cancer Conference. Madrid, Spain. November 16-17, 2011.
    Breast Cancer Res. 2011;13 Suppl 2:O1-15.
    PubMed     Text format     Related articles   
    
    
    
    
41. NISHIOKA T , Kim HS, Luo LY, Huang Y, et al
    Sensitization of epithelial growth factor receptors by nicotine exposure to promote breast cancer cell growth.
    Breast Cancer Res. 2011;13:R113.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. MULLIGAN AM , Couch FJ, Barrowdale D, Domchek SM, et al
    Common breast cancer susceptibility alleles are associated with tumor subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.
    Breast Cancer Res. 2011;13:R110.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. JACQUEMIER J , Boher JM, Roche H, Esterni B, et al
    Protein expression, survival and docetaxel benefit in node-positive breast cancer treated with adjuvant chemotherapy in the FNCLCC - PACS 01 randomized trial.
    Breast Cancer Res. 2011;13:R109.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. CHODOSH LA
    Breast cancer: current state and future promise.
    Breast Cancer Res. 2011;13:113.
    PubMed     Text format     Related articles   
    
    
    
    
45. DRASIN DJ , Robin TP, Ford HL
    Breast cancer epithelial-to-mesenchymal transition: examining the functional consequences of plasticity.
    Breast Cancer Res. 2011;13:226.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. HUANG Y , Nayak S, Jankowitz R, Davidson NE, et al
    Epigenetics in breast cancer: what's new?
    Breast Cancer Res. 2011;13:225.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. PLACE AE , Jin Huh S, Polyak K
    The microenvironment in breast cancer progression: biology and implications for treatment.
    Breast Cancer Res. 2011;13:227.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. MILLER TW , Rexer BN, Garrett JT, Arteaga CL, et al
    Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer.
    Breast Cancer Res. 2011;13:224.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. BOYD NF , Martin LJ, Yaffe MJ, Minkin S, et al
    Mammographic density and breast cancer risk: current understanding and future prospects.
    Breast Cancer Res. 2011;13:223.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
50. HATHAWAY HJ , Butler KS, Adolphi NL, Lovato DM, et al
    Detection of breast cancer cells using targeted magnetic nanoparticles and ultra-sensitive magnetic field sensors.
    Breast Cancer Res. 2011;13:R108.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. LIPS EH , Laddach N, Savola SP, Vollebergh MA, et al
    Quantitative copy number analysis by Multiplex Ligation-dependent Probe Amplification (MLPA) of BRCA1-associated breast cancer regions identifies BRCAness.
    Breast Cancer Res. 2011;13:R107.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. MENDOZA-VILLANUEVA D , Zeef L, Shore P
    Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFbeta-dependent expression of the Wnt antagonist, Sclerostin.
    Breast Cancer Res. 2011;13:R106.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. LOKATE M , Peeters PH, Peelen LM, Haars G, et al
    Mammographic density and breast cancer risk: the role of the fat surrounding the fibroglandular tissue.
    Breast Cancer Res. 2011;13:R103.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. CARDIFF RD , Couto S, Bolon B
    Three interrelated themes in current breast cancer research: gene addiction, phenotypic plasticity, and cancer stem cells.
    Breast Cancer Res. 2011;13:216.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. IGNATIADIS M , Reinholz M
    Minimal residual disease and circulating tumor cells in breast cancer.
    Breast Cancer Res. 2011;13:222.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. WEI L , Liu TT, Wang HH, Hong HM, et al
    Hsp27 participates in the maintenance of breast cancer stem cells through regulation of epithelial-mesenchymal transition and nuclear factor-kappa B.
    Breast Cancer Res. 2011;13:R101.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. PETTERSSON A , Hankinson SE, Willett W, Lagiou P, et al
    Non-dense mammographic area and risk of breast cancer.
    Breast Cancer Res. 2011;13:R100.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. TWOROGER SS , Rosner BA, Willett WC, Hankinson SE, et al
    The combined influence of multiple sex and growth hormones on risk of postmenopausal breast cancer: a nested case-control study.
    Breast Cancer Res. 2011;13:R99.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. JANKOWITZ RC , Cooper K, Erlander M, Ma XJ, et al
    Prognostic utility of the breast cancer index and comparison to Adjuvant! Online in a clinical case series of early breast cancer.
    Breast Cancer Res. 2011;13:R98.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. BLACKBURN AC
    Rats: gnawing through the barriers to understanding genetic susceptibility and breast cancer.
    Breast Cancer Res. 2011;13:112.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. FURTH PA , Nakles RE, Millman S, Diaz-Cruz ES, et al
    Signal transducer and activator of transcription 5 as a key signaling pathway in normal mammary gland developmental biology and breast cancer.
    Breast Cancer Res. 2011;13:220.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. RODY A , Karn T, Liedtke C, Pusztai L, et al
    A clinically relevant gene signature in triple negative and basal-like breast cancer.
    Breast Cancer Res. 2011;13:R97.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. OH K , Ko E, Kim HS, Park AK, et al
    Transglutaminase 2 facilitates the distant hematogenous metastasis of breast cancer by modulating interleukin-6 in cancer cells.
    Breast Cancer Res. 2011;13:R96.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
64. KNOWLDEN JM , Gee JM, Barrow D, Robertson JF, et al
    erbB3 recruitment of insulin receptor substrate-1 impacts on insulin-like growth factor receptor signalling in oestrogen receptor positive breast cancer cell lines.
    Breast Cancer Res. 2011;13:R93.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. WANG DY , Done SJ, McCready DR, Boerner S, et al
    A new gene expression signature, the ClinicoMolecular Triad Classification, may improve prediction and prognostication of breast cancer at the time of diagnosis.
    Breast Cancer Res. 2011;13:R92.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. JAMIESON WL , Zhang Y, Fong AM, Meucci O, et al
    The chemokine receptor CX3CR1 is directly involved in the arrest of breast cancer cells to the skeleton.
    Breast Cancer Res. 2011;13:R91.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. PIGGOTT L , Omidvar N, Marti-Perez S, Eberl M, et al
    Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL.
    Breast Cancer Res. 2011;13:R88.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. SIHTO H , Lundin J, Lundin M, Lehtimaki T, et al
    Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study.
    Breast Cancer Res. 2011;13:R87.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. APPAIAH HN , Goswami CP, Mina LA, Badve S, et al
    Persistent upregulation of U6:SNORD44 small RNA ratio in the serum of breast cancer patients.
    Breast Cancer Res. 2011;13:R86.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
70. HUANG C , Park CC, Hilsenbeck SG, Ward R, et al
    beta1 Integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinib.
    Breast Cancer Res. 2011;13:R84.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. WENNEMERS M , Bussink J, Scheijen B, Nagtegaal ID, et al
    Tribbles homolog 3 denotes a poor prognosis in breast cancer and is involved in hypoxia response.
    Breast Cancer Res. 2011;13:R82.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. SMITS BM , Sharma D, Samuelson DJ, Woditschka S, et al
    The non-protein coding breast cancer susceptibility locus Mcs5a acts in a non-mammary cell-autonomous fashion through the immune system and modulates T-cell homeostasis and functions.
    Breast Cancer Res. 2011;13:R81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. PLUMMER R
    Poly(ADP-ribose) polymerase inhibition: a new direction for BRCA and triple-negative breast cancer?
    Breast Cancer Res. 2011;13:218.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. CHLEBOWSKI RT
    Vitamin D and breast cancer: interpreting current evidence.
    Breast Cancer Res. 2011;13:217.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. CLARKE R
    Cannibalism, cell survival, and endocrine resistance in breast cancer.
    Breast Cancer Res. 2011;13:311.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. HOLLIDAY DL , Speirs V
    Choosing the right cell line for breast cancer research.
    Breast Cancer Res. 2011;13:215.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. TRAM E , Ibrahim-Zada I, Briollais L, Knight JA, et al
    Identification of germline alterations of the mad homology 2 domain of SMAD3 and SMAD4 from the Ontario site of the breast cancer family registry (CFR).
    Breast Cancer Res. 2011;13:R77.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
78. CONNOLLY D , Yang Z, Castaldi M, Simmons N, et al
    Septin 9 isoform expression, localization and epigenetic changes during human and mouse breast cancer progression.
    Breast Cancer Res. 2011;13:R76.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. TVEITO S , Andersen K, Karesen R, Fodstad O, et al
    Analysis of EpCAM positive cells isolated from sentinel lymph nodes of breast cancer patients identifies subpopulations of cells with distinct transcription profiles.
    Breast Cancer Res. 2011;13:R75.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
80. VRIELING A , Hein R, Abbas S, Schneeweiss A, et al
    Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study.
    Breast Cancer Res. 2011;13:R74.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. SHOSTAK K , Chariot A
    NF-kappaB, stem cells and breast cancer: the links get stronger.
    Breast Cancer Res. 2011;13:214.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. GOLDGAR DE , Healey S, Dowty JG, Da Silva L, et al
    Rare variants in the ATM gene and risk of breast cancer.
    Breast Cancer Res. 2011;13:R73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
83. HUIJTS PE , van Dongen M, de Goeij MC, van Moolenbroek AJ, et al
    Allele-Specific regulation of FGFR2 expression is cell type-dependent and may increase breast cancer risk through a paracrine stimulus involving FGF10.
    Breast Cancer Res. 2011;13:R72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
84. MULLER V , Riethdorf S, Rack B, Janni W, et al
    Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cancer.
    Breast Cancer Res. 2011;13:R71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
85. JOHAR S
    Correction: Functional magnetic resonance: biomarkers of response in breast cancer.
    Breast Cancer Res. 2011;13:R70.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
86. JOHAR S
    Correction: An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer.
    Breast Cancer Res. 2011;13:R69.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. COLOMBO PE , Milanezi F, Weigelt B, Reis-Filho JS, et al
    Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction.
    Breast Cancer Res. 2011;13:212.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. JOHAR S
    Correction: Functional magnetic resonance: biomarkers of response in breast cancer.
    Breast Cancer Res. 2011;13:405.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
89. VAN DER HAGE JA , Mieog JS, van de Velde CJ, Putter H, et al
    Impact of established prognostic factors and molecular subtype in very young breast cancer patients: pooled analysis of four EORTC randomized controlled trials.
    Breast Cancer Res. 2011;13:R68.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
90. GIULIANO M , Giordano A, Jackson S, Hess KR, et al
    Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment.
    Breast Cancer Res. 2011;13:R67.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
91. KODERA Y , Katanasaka Y, Kitamura Y, Hitoshi T, et al
    Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.
    Breast Cancer Res. 2011;13:R66.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
92. PATNAIK JL , Byers T, Diguiseppi C, Dabelea D, et al
    Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study.
    Breast Cancer Res. 2011;13:R64.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
93. CLEMENTZ AG , Rogowski AS, Pandya K, Miele L, et al
    Notch-1 and Notch-4 are Novel Gene Targets of PEA3 in Breast Cancer: Novel Therapeutic Implications.
    Breast Cancer Res. 2011;13:R63.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
94. MOLLOY TJ , Bosma AJ, Baumbusch LO, Synnestvedt M, et al
    The prognostic significance of tumor cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patients.
    Breast Cancer Res. 2011;13:R61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
95. TAKEBE N , Warren RQ, Ivy SP
    Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transition.
    Breast Cancer Res. 2011;13:211.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
96. SALOUSTROS E , Perraki M, Apostolaki S, Kallergi G, et al
    Cytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapse.
    Breast Cancer Res. 2011;13:R60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
97. KALLERGI G , Papadaki MA, Politaki E, Mavroudis D, et al
    Epithelial-mesenchymal transition markers expressed in circulating tumor cells of early and metastatic breast cancer patients.
    Breast Cancer Res. 2011;13:R59.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
98. RADISKY DC
    miR-200c at the nexus of epithelial-mesenchymal transition, resistance to apoptosis, and the breast cancer stem cell phenotype.
    Breast Cancer Res. 2011;13:110.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
99. COONEY CA , Jousheghany F, Yao-Borengasser A, Phanavanh B, et al
    Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells.
    Breast Cancer Res. 2011;13:R58.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
100. PARMAR S , Stingl JC, Huber-Wechselberger A, Kainz A, et al
     Impact of UGT2B7His268Tyr polymorphism on the outcome of adjuvant epirubicin treatment in breast cancer.
     Breast Cancer Res. 2011;13:R57.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
101. LU L , Zhang C, Zhu G, Irwin M, et al
     Telomerase Expression and Telomere Length in Breast Cancer and their Associations with Adjuvant Treatment and Disease Outcome.
     Breast Cancer Res. 2011;13:R56.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
102. ALLIN KH , Nordestgaard BG, Flyger H, Bojesen SE, et al
     Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study.
     Breast Cancer Res. 2011;13:R55.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     May 2011
103. HAN J , Hendzel MJ, Allalunis-Turner J
     Notch signaling as a therapeutic target for breast cancer treatment?
     Breast Cancer Res. 2011;13:210.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
104. REGAN MM , Price KN, Giobbie-Hurder A, Thurlimann B, et al
     Interpreting breast international group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer.
     Breast Cancer Res. 2011;13:209.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
105. HOFBAUER LC , Rachner TD, Hamann C
     From bone to breast and back - the bone cytokine RANKL and breast cancer.
     Breast Cancer Res. 2011;13:107.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
106. SUTHERLAND RL
     Endocrine resistance in breast cancer: new roles for ErbB3 and ErbB4.
     Breast Cancer Res. 2011;13:106.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
107. LI J , Seibold P, Chang-Claude J, Flesch-Janys D, et al
     Coffee consumption modifies risk of estrogen-receptor negative breast cancer.
     Breast Cancer Res. 2011;13:R49.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
108. ELIASSEN AH , Spiegelman D, Hollis BW, Horst RL, et al
     Plasma 25-hydroxyvitamin D and risk of breast cancer in the Nurses' Health Study II.
     Breast Cancer Res. 2011;13:R50.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     April 2011
109. BAROK M , Tanner M, Koninki K, Isola J, et al
     Trastuzumab-DM1 causes tumor growth inhibition by mitotic catastrophe in trastuzumab-resistant breast cancer cells in vivo.
     Breast Cancer Res. 2011;13:R46.
     PubMed     Text format     Related articles   
     
     
     
     
110. ANTONOVA L , Aronson K, Mueller CR
     Stress and breast cancer: from epidemiology to molecular biology.
     Breast Cancer Res. 2011;13:208.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
111. LINDBERG K , Helguero LA, Omoto Y, Gustafsson JA, et al
     Estrogen receptor beta represses Akt signaling in breast cancer cells via downregulation of HER2/HER3 and upregulation of PTEN - implications for tamoxifen sensitivity.
     Breast Cancer Res. 2011;13:R43.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
112. NYANTE SJ , Faupel-Badger JM, Sherman ME, Pfeiffer RM, et al
     Genetic variation in PRL and PRLR, and relationships with serum prolactin levels and breast cancer risk: results from a population-based case-control study in Poland.
     Breast Cancer Res. 2011;13:R42.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
113. LINDEMAN GJ , Visvader JE
     Cell fate takes a slug in BRCA1-associated breast cancer.
     Breast Cancer Res. 2011;13:306.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
114. CLEZARDIN P
     Therapeutic targets for bone metastases in breast cancer.
     Breast Cancer Res. 2011;13:207.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
115. MARTRAT G , Maxwell CA, Tominaga E, Porta M, et al
     Exploring the link between MORF4L1 and risk of breast cancer.
     Breast Cancer Res. 2011;13:R40.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
116. ZHANG W , Becciolini A, Biggeri A, Pacini P, et al
     Second malignancies in breast cancer patients following radiotherapy: a study in Florence, Italy.
     Breast Cancer Res. 2011;13:R38.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
117. LEE E , Schumacher F, Lewinger JP, Neuhausen SL, et al
     The association of polymorphisms in hormone metabolism pathway genes, menopausal hormone therapy, and breast cancer risk: a nested case-control study in the California Teachers Study cohort.
     Breast Cancer Res. 2011;13:R37.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
118. NADERI A , Chia KM, Liu J
     Synergy between inhibitors of androgen receptor and MEK has therapeutic implications in estrogen receptor-negative breast cancer.
     Breast Cancer Res. 2011;13:R36.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
119. TENG YH , Tan WJ, Thike AA, Cheok TY, et al
     Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy.
     Breast Cancer Res. 2011;13:R35.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
120. ADAMO B , Anders CK
     Stratifying triple-negative breast cancer: which definition(s) to use?
     Breast Cancer Res. 2011;13:105.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     March 2011
121. OH SW , Park CY, Lee ES, Yoon YS, et al
     Adipokines, insulin resistance, metabolic syndrome, and breast cancer recurrence: a cohort study.
     Breast Cancer Res. 2011;13:R34.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
122. DE SANTI M , Galluzzi L, Lucarini S, Paoletti MF, et al
     The indole-3-carbinol cyclic tetrameric derivative CTet inhibits cell proliferation via overexpression of p21/CDKN1A in both estrogen receptor positive and triple negative breast cancer cell lines.
     Breast Cancer Res. 2011;13:R33.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
123. MCSHERRY EA , Brennan K, Hudson L, Hill AD, et al
     Breast cancer cell migration is regulated through junctional adhesion molecule-A-mediated activation of Rap1 GTPase.
     Breast Cancer Res. 2011;13:R31.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
124. TRAN LA , Wilson LJ
     Nanomedicine: making controllable magnetic drug delivery possible for the treatment of breast cancer.
     Breast Cancer Res. 2011;13:303.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
125. BLANCO MA , Kang Y
     Signaling pathways in breast cancer metastasis - novel insights from functional genomics.
     Breast Cancer Res. 2011;13:206.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
126. HUTCHESON IR , Goddard L, Barrow D, McClelland RA, et al
     Fulvestrant-induced expression of ErbB3 and ErbB4 receptors sensitizes ER-positive breast cancer cells to heregulin beta1.
     Breast Cancer Res. 2011;13:R29.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
127. WU X , Subramaniam M, Grygo SB, Sun Z, et al
     Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen.
     Breast Cancer Res. 2011;13:R27.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
128. ZU X , Ma J, Liu H, Liu F, et al
     Pro-oncogene pokemon promotes breast cancer progression by upregulating survivin expression.
     Breast Cancer Res. 2011;13:R26.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
129. BLIXT O , Bueti D, Burford B, Allen D, et al
     Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis.
     Breast Cancer Res. 2011;13:R25.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
130. HANNAFON BN , Sebastiani P, de Las Morenas A, Lu J, et al
     Expression of microRNAs and their gene targets are dysregulated in pre-invasive breast cancer.
     Breast Cancer Res. 2011;13:R24.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
131. BERLATO C , Chan KV, Price AM, Canosa M, et al
     Alternative TFAP2A isoforms have distinct activities in breast cancer.
     Breast Cancer Res. 2011;13:R23.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
132. KEAM B , Im SA, Lee KH, Han SW, et al
     Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis.
     Breast Cancer Res. 2011;13:R22.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
133. SANCHEZ CG , Ma CX, Crowder RJ, Guintoli T, et al
     Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer.
     Breast Cancer Res. 2011;13:R21.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     February 2011
134. O'FLYNN EA , Desouza NM
     Functional magnetic resonance: biomarkers of response in breast cancer.
     Breast Cancer Res. 2011;13:204.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
135. CHAN P , Moeller A, Liu MC, Sceneay JE, et al
     he expression of the ubiquitin ligase SIAH (seven in absentia homolog) 2 is mediated through gene copy number in breast cancer and is associated with a basal-like phenotype and p53 expression.
     Breast Cancer Res. 2011;13:R19.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
136. MAY CD , Sphyris N, Evans KW, Werden SJ, et al
     Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression.
     Breast Cancer Res. 2011;13:202.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
137. SILVESTRI V , Rizzolo P, Falchetti M, Zanna I, et al
     Mutation screening of RAD51C in male breast cancer patients.
     Breast Cancer Res. 2011;13:404.
     PubMed     Text format     Related articles   
     
     
     
     
138. SALAZAR MD , Ratnam M, Patki M, Kisovic I, et al
     During hormone depletion or tamoxifen treatment of breast cancer cells the estrogen receptor apoprotein supports cell cycling through the retinoic acid receptor alpha1 apoprotein.
     Breast Cancer Res. 2011;13:R18.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
139. HENEGHAN HM , Miller N, Kerin MJ
     Circulating microRNAs: promising breast cancer Biomarkers.
     Breast Cancer Res. 2011;13:402.
     PubMed     Text format     Related articles   
     
     
     
     
140. ROTH C , Rack B, Muller V, Janni W, et al
     Circulating microRNAs: promising breast cancer biomarkers - authors' response.
     Breast Cancer Res. 2011;13:403.
     PubMed     Text format     Related articles   
     
     
     
     
141. FOX SB , Generali D, Berruti A, Brizzi MP, et al
     The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1alpha and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen.
     Breast Cancer Res. 2011;13:R16.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
142. SWANTON C , Burrell RA, Futreal PA
     Breast cancer genome heterogeneity: a challenge to personalised medicine?
     Breast Cancer Res. 2011;13:104.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     January 2011
143. SMITH LD , Tesoriero AA, Wong EM, Ramus SJ, et al
     Contribution of large genomic BRCA1 alterations to early-onset breast cancer selected for family history and tumour morphology: a report from The Breast Cancer Family Registry.
     Breast Cancer Res. 2011;13:R14.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
144. YU JC , Hsiung CN, Hsu HM, Bao BY, et al
     Genetic variation in the genome-wide predicted estrogen response element-related sequences is associated with breast cancer development.
     Breast Cancer Res. 2011;13:R13.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
145. BRENNAN DJ , Laursen H, O'Connor DP, Borgquist S, et al
     Tumor specific HMG-CoA reductase expression in primary pre-menopausal breast cancer predicts response to tamoxifen.
     Breast Cancer Res. 2011;13:R12.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
146. ARENDT LM , Rugowski DE, Grafwallner-Huseth TA, Garcia-Barchino MJ, et al
     Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer.
     Breast Cancer Res. 2011;13:R11.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
147. LI Y , Li Y, Wedren S, Li G, et al
     Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor positive breast cancer.
     Breast Cancer Res. 2011;13:R10.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
148. RODENHISER DI , Andrews JD, Vandenberg TA, Chambers AF, et al
     Gene signatures of breast cancer progression and metastasis.
     Breast Cancer Res. 2011;13:201.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
149. MAO JJ , Su HI, Feng R, Donelson ML, et al
     Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors.
     Breast Cancer Res. 2011;13:R8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
150. BOURDON JC , Khoury MP, Diot A, Baker L, et al
     p53 mutant breast cancer patients expressing p53gamma have as good a prognosis as wild-type p53 breast cancer patients.
     Breast Cancer Res. 2011;13:R7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
151. LE CALVEZ-KELM F , Lesueur F, Damiola F, Vallee M, et al
     Rare, evolutionarily unlikely missense substitutions in CHEK2 contribute to breast cancer susceptibility: results from a breast cancer family registry (CFR) case-control mutation screening study.
     Breast Cancer Res. 2011;13:R6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
152. BREKMAN A , Singh KE, Polotskaia A, Kundu N, et al
     A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation.
     Breast Cancer Res. 2011;13:R3.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
153. YAN LX , Wu QN, Zhang Y, Li YY, et al
     Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth.
     Breast Cancer Res. 2011;13:R2.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
154. TIWARY R , Yu W, Sanders BG, Kline K, et al
     alpha-TEA cooperates with chemotherapeutic agents to induce apoptosis of p53 mutant, triple negative human breast cancer cells via activating p73.
     Breast Cancer Res. 2011;13:R1.
     PubMed     Text format     Related articles    Abstract available
     
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: